Church & Dwight Co., Inc. (NYSE:CHD) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 19.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 7,336,046 shares of the company’s stock after acquiring an additional 1,190,154 shares during the quarter. JPMorgan Chase & Co.’s holdings in Church & Dwight were worth $768,157,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Board of the Pension Protection Fund acquired a new position in shares of Church & Dwight in the 4th quarter valued at about $639,000. Oddo BHF Asset Management Sas bought a new position in shares of Church & Dwight during the third quarter valued at approximately $5,934,000. American Century Companies Inc. raised its position in shares of Church & Dwight by 0.5% during the 4th quarter. American Century Companies Inc. now owns 1,426,177 shares of the company’s stock worth $149,335,000 after purchasing an additional 6,425 shares during the period. Financial Enhancement Group LLC boosted its position in Church & Dwight by 456.2% during the 4th quarter. Financial Enhancement Group LLC now owns 60,585 shares of the company’s stock valued at $6,232,000 after purchasing an additional 49,693 shares during the period. Finally, Merit Financial Group LLC grew its stake in Church & Dwight by 131.0% during the 4th quarter. Merit Financial Group LLC now owns 5,769 shares of the company’s stock worth $604,000 after buying an additional 3,272 shares during the last quarter. Institutional investors and hedge funds own 86.60% of the company’s stock.

Insider Transactions at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the firm’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the transaction, the executive vice president now directly owns 10,497 shares in the company, valued at $1,217,442.06. This trade represents a 83.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Rene Hemsey sold 11,060 shares of the stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now directly owns 6,437 shares in the company, valued at approximately $707,941.26. This represents a 63.21 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 65,570 shares of company stock worth $7,538,449 in the last 90 days. 2.00% of the stock is owned by insiders.

Church & Dwight Trading Up 0.7 %

Shares of NYSE CHD opened at $109.14 on Friday. The business has a 50-day moving average price of $107.65 and a two-hundred day moving average price of $105.93. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $26.86 billion, a PE ratio of 46.05, a PEG ratio of 3.32 and a beta of 0.57. Church & Dwight Co., Inc. has a one year low of $96.35 and a one year high of $116.46.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter in the previous year, the company posted $0.65 EPS. As a group, analysts predict that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Friday, February 14th were paid a $0.295 dividend. The ex-dividend date of this dividend was Friday, February 14th. This is a boost from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a yield of 1.08%. Church & Dwight’s payout ratio is 49.79%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. Piper Sandler reduced their price target on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $105.00 price target on shares of Church & Dwight in a report on Monday, February 3rd. JPMorgan Chase & Co. lowered their target price on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a research report on Friday, February 21st. Truist Financial increased their price target on Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Monday, February 3rd. Finally, Barclays upped their price objective on shares of Church & Dwight from $93.00 to $97.00 and gave the stock an “underweight” rating in a report on Thursday. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $111.81.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.